Rubiscolin-6, a δ opioid peptide derived from spinach Rubisco, has anxiolytic effect via activating σ1 and dopamine D1 receptors

Peptides

Volumn 28, Issue 10, 2007, Pages 1998-2003

  Hirata, Hajime ^a   Sonoda, Soushi ^a   Agui, Shun ^a   Yoshida, Mariko ^a   Ohinata, Kousaku ^a   Yoshikawa, Masaaki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Anxiolytic effect; Dopamine receptor; Opioid peptide; Rubisco; Sigma receptor

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; DELTA OPIATE PEPTIDE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; NALTRINDOLE; OPIATE PEPTIDE; RACLOPRIDE; RIBULOSEBISPHOSPHATE CARBOXYLASE; RUBISCOLIN 6; SIGMA 1 OPIATE RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINACH; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; MALE; MICE; MICE, INBRED STRAINS; PEPTIDE FRAGMENTS; RECEPTORS, DOPAMINE D1; RECEPTORS, SIGMA; RIBULOSE-BISPHOSPHATE CARBOXYLASE;

MUS; SPINACIA OLERACEA;

EID: 34548701780     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.07.024     Document Type: Article

References (32)

1. Asakawa A., Inui A., Momose K., Ueno N., Fujino M.A., and Kasuga M. Endomorphins have orexigenic and anxiolytic activities in mice. Neuroreport 13 (1998) 2265-2267
2. Billet F., Dourmap N., and Constentin J. Involvement of corticostriatal glutamatergic terminals in striatal dopamine release elicited by stimulation of δ opioid receptors. Eur J Neurosci 20 (2004) 2629-2638
3. Freeman F.M., and Young I.G. Inhibition of passive avoidance memory formation in the day-old chick by the opioid cytochrophine-4. Learn Mem 7 (2000) 213-219
4. Filliol D., Ghozland S., Chluba J., Martin M., Matthes W.D.H., Simonin F., et al. Mice deficient for δ-and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25 (2000) 195-200
5. Fukudome S., and Yoshikawa M. Opioid peptide derived from wheat gluten: their isolation and characterization. FEBS Lett 296 (1992) 107-111
6. Hartman F.C., and Harpel M.R. Structure, function, regulation and assembly of d-ribulose-1,5-bisphosphate carboxylase/oxygenase. Ann Rev Biochem 63 (1994) 197-234
7. Hayashi T., and Su T.P. Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders. CNS Drugs 18 5 (2004) 269-284
8. 2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135 (2005) 213-225
9. 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems. Eur J Pharmacol 319 (1997) 165-172
10. Mansour A., Fox A.C., Akil H., and Watson J.S. Opioid-receptor mRNA expression in the rat CNS: anatomical and function implication. Trends Neurosci 18 (1995) 22-29
11. Martin W.R., Eades C.G., Thompson J.A., Huppler R.E., and Gilbert P.E. The effects of morphine- and nalophine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197 (1976) 517-532
12. 1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 312 (1996) 267-271
13. 3H]SKF-10,047 binding to s1 receptor in the mouse forebrain. J Neurosci Res 46 (1996) 734-743
14. Meisel H. Biochemical properties of regulatory peptides from milk proteins. Biopolymers 43 (1997) 119-128
15. Momose K., Inui A., Asakawa A., Ueno N., Nakajima M., and Kasuga M. Anxiolytic effect of motilin and reversal with GM-109, a motilin antagonist, in mice. Peptide 19 (1998) 1739-1742
16. Moore M., and Bloom F.E. Central catecholamine neuron system: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1 (1978) 129-169
17. Nakajima M., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., et al. Neuropeptide Y produces anxiety via Y2-type receptors. Peptides 19 (1998) 359-363
18. Nemeroff C.B., and Bissette G. Neuropeptide, dopamine and schizophrenia. Annu NY Acad Sci 537 (1988) 273-291
19. Oshiro Y., Sakurai Y., Sato S., Kurahashi N., Tanaka T., Kikuchi T., et al. 3,4-Dihydro-2(1H)-quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[3-[4-(3-chlorophenyle)-1-piperazinyl]propyl]-3,4-dihydro-5-methoxy-2(1H)-quinolinone and its derivatives. J Med Chem 43 (2000) 177-189
20. Quirion R., Chichportiche R., Contreras P., Johnson K., Lodge D., and Tam S. Classification and nemenclature of phencyclidine and sigma receptor sites. Trends Neurol Sci 10 (1987) 444-446
21. Ramamoorthy J.D., Ramamoorthy S., Mahesh V.B., Leibach F.H., and Ganapathy V. Cocain sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma calls. Endocrinology 136 (1995) 924-932
22. Saitoh A., Kimura Y., Suzuki T., Kawai K., Nagase H., and Kamei J. Potential anxiolytic and antidepressant-like activities of SNC-80, a selective δ-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95 (2004) 374-380
23. Ueno N., Asakawa A., Satoh Y., and Inui A. Increased circulating cholecystokinin contributes to anorexia and anxiety behavior in mice overexpressing pancreatic polypeptide. Regul Pept 141 1-3 (2007) 8-11
24. Ukai M., Maeda H., Nanya Y., Kameyama T., and Matsuno K. Benefical effects of acute and repeated administration of σ receptor agonists on behavior despair in mice exposed to tail suspension. Pharmacol Biochem Behav 61 (1998) 247-252
25. Ukai M., Takada A., Sasaki Y., and Kameyama T. Stimulation of delta1- and delta2-opioid receptor produces amnesia in mice. Eur J Pharmacol 338 (1997) 1-6
26. Ukai M., Watanabe M., and Kameyama T. Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, impair passive avoidance learning in mice. Eur J Pharmacol 421 (2001) 115-119
27. Ukai M., Watanabe M., and Kameyama T. Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice. Eur J Pharmacol 395 (2000) 211-215
28. Yamada M., Nishigami T., Nakasho K., Nishimoto Y., and Miyaji H. Relationship between sigma-like site and progesterone-binding site of adult male rat lever microsomes. Hepatology 20 (1994) 1271-1280
29. Yang S., Kawamura Y., and Yoshikawa M. Effect of rubiscolin-6, delta opioid peptide derived from Rubisco, on memory consolidation. Peptides 24 (2003) 325-328
30. Yang S., Sonoda S., Chen L., and Yoshikawa M. Structure-activity relationship of rubiscolins as delta opioid peptides. Peptides 24 (2003) 503-508
31. Yang S., Yunden J., Sonoda S., Doyama N., Liplowski A.W., Kawamura Y., et al. Rubiscolin, a delta selective opioid peptide derived from plant Rubisco. FEBS Lett 509 (2001) 213-217
32. Yoshikawa M., Takahashi M., and Yang S. Delta opioid peptides derived from plant proteins. Curr Pharm Des 9 (2003) 1325-1330